You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Mallinckrodt
Medtronic
McKinsey
McKesson

Last Updated: April 8, 2020

DrugPatentWatch Database Preview

Selegiline - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for selegiline and what is the scope of patent protection?

Selegiline is the generic ingredient in four branded drugs marketed by Somerset, Apotex, Dava Pharms Inc, Lannett Co Inc, Rising, Bausch, Acp Nimble, Allied, Apotex Inc, Boscogen, Chartwell Molecules, G And W Labs Inc, and Mylan, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for selegiline. One supplier is listed for this compound.

Drug Prices for selegiline

See drug prices for selegiline

Recent Clinical Trials for selegiline

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of OxfordN/A
University of South FloridaPhase 4
Mood and Anxiety Research, IncPhase 3

See all selegiline clinical trials

Recent Litigation for selegiline

Identify potential future generic entrants

District Court Litigation
Case NameDate
Somerset Pharmaceuticals Inc. v. Dudas2007-05-22

See all selegiline litigation

Medical Subject Heading (MeSH) Categories for selegiline
Synonyms for selegiline
(-)-(N)-Methyl-N-((1R)-1-methyl-2-phenylethyl)prop-2-yn-1-amine
(-)-Deprenil
(-)-selegiline
(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine
(R)-(-)-N-Methyl-N-(1-phenyl-2-propyl)-2-propinylamin
(r)-(-)-n,2-dimethyl-n-2-propynylphenethylamine
(R)-(-)-N,alpha-Dimethyl-N-2-propinylphenethylamine
(R)-(-)-Selegiline
14611-51-9
2K1V7GP655
AKOS000281115
Anipryl
API0009080
BDBM15579
Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl-, (R)-
Benzeneethanamine, N,alpha-methyl-N-2-propynyl-, (alphaR)-
BPBio1_000687
BRD-K86434416-001-02-7
BRD-K86434416-003-03-1
BRD-K86434416-003-06-4
BSPBio_000623
BSPBio_001589
C07245
Carbex
CHEBI:9086
CHEMBL972
D03731
DB01037
Deprenyl
DTXSID6023575
Eldepryl
Emsam
Emsam (TN)
FT-0688371
GTPL6639
HMS1791P11
HMS1989P11
HMS2089D09
HMS3402P11
Jumex
L-Deprenalin
L-Deprenyl
l-E 250
LS-30156
methyl(1-phenylpropan-2-yl)(prop-2-yn-1-yl)amine
methyl[(2R)-1-phenylpropan-2-yl](prop-2-yn-1-yl)amine
methyl[(2R)-1-phenylpropan-2-yl]prop-2-yn-1-ylamine
MEZLKOACVSPNER-GFCCVEGCSA-N
N-methyl-N-[(1R)-1-methyl-2-phenylethyl]prop-2-yn-1-amine
N-methyl-N-[(2R)-1-phenylpropan-2-yl]prop-2-yn-1-amine
NCGC00024994-01
NCGC00024994-02
NCGC00024994-03
NCGC00024994-04
Otrasel
Prestwick0_000552
Prestwick1_000552
Prestwick2_000552
Prestwick3_000552
Q47495783
R(-)-Selegiline solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
SCHEMBL22232
Selegene
Selegilina
Selegilina [INN-Spanish]
Selegiline (USAN/INN)
Selegiline [INN:BAN]
Selegiline [USAN:INN:BAN]
Selegiline Transdermal System (STS) patch
Selegiline, (R)-Isomer
Selegilinum
Selegilinum [INN-Latin]
Selegyline
selgene
SPBio_002544
STK640578
UNII-2K1V7GP655
UNII-DPF682Q08V component MEZLKOACVSPNER-GFCCVEGCSA-N
UNII-DPF682Q08V component MEZLKOACVSPNER-LBPRGKRZSA-N
US8633208, Deprenyl
Yumex
Zalapar
Zelapar
ZINC19632633

US Patents and Regulatory Information for selegiline

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074866-001 Nov 26, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Lannett Co Inc SELEGILINE HYDROCHLORIDE selegiline hydrochloride CAPSULE;ORAL 075145-001 Sep 15, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Chartwell Molecules SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074565-001 Aug 2, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Somerset ELDEPRYL selegiline hydrochloride CAPSULE;ORAL 020647-001 May 15, 1996 DISCN Yes No   Start Trial   Start Trial   Start Trial
Allied SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074672-001 Apr 1, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Chartwell Molecules SELEGILINE HYDROCHLORIDE selegiline hydrochloride TABLET;ORAL 074641-001 Aug 2, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006 RX Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for selegiline

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-001 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-003 Feb 27, 2006   Start Trial   Start Trial
Somerset EMSAM selegiline FILM, EXTENDED RELEASE;TRANSDERMAL 021336-002 Feb 27, 2006   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Mallinckrodt
Medtronic
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.